BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

306 related articles for article (PubMed ID: 32273035)

  • 1. Atrial Fibrillation: JACC Council Perspectives.
    Chung MK; Refaat M; Shen WK; Kutyifa V; Cha YM; Di Biase L; Baranchuk A; Lampert R; Natale A; Fisher J; Lakkireddy DR;
    J Am Coll Cardiol; 2020 Apr; 75(14):1689-1713. PubMed ID: 32273035
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Atrial fibrillation management: evaluating rate vs rhythm control.
    Nguyen T; Jolly U; Sidhu K; Yee R; Leong-Sit P
    Expert Rev Cardiovasc Ther; 2016 Jun; 14(6):713-24. PubMed ID: 26960034
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Pulmonary Vein Antral Isolation and Nonpulmonary Vein Trigger Ablation Are Sufficient to Achieve Favorable Long-Term Outcomes Including Transformation to Paroxysmal Arrhythmias in Patients With Persistent and Long-Standing Persistent Atrial Fibrillation.
    Liang JJ; Elafros MA; Muser D; Pathak RK; Santangeli P; Zado ES; Frankel DS; Supple GE; Schaller RD; Deo R; Garcia FC; Lin D; Hutchinson MD; Riley MP; Callans DJ; Marchlinski FE; Dixit S
    Circ Arrhythm Electrophysiol; 2016 Nov; 9(11):. PubMed ID: 27784738
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Improving outcomes in patients with atrial fibrillation: rationale and design of the Early treatment of Atrial fibrillation for Stroke prevention Trial.
    Kirchhof P; Breithardt G; Camm AJ; Crijns HJ; Kuck KH; Vardas P; Wegscheider K
    Am Heart J; 2013 Sep; 166(3):442-8. PubMed ID: 24016492
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Anticoagulation use and clinical outcomes after catheter ablation in patients with persistent and longstanding persistent atrial fibrillation.
    Liang JJ; Elafros MA; Mullen MT; Muser D; Hayashi T; Enriquez A; Pathak RK; Zado ES; Santangeli P; Arkles JS; Schaller RD; Supple GE; Frankel DS; Garcia FC; Deo R; Lin D; Riley MP; Nazarian S; Dixit S; Marchlinski FE; Callans DJ
    J Cardiovasc Electrophysiol; 2018 Jun; 29(6):823-832. PubMed ID: 29513397
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Evaluation of practice patterns in the treatment of atrial fibrillation among the commercially insured.
    Liu J; Sylwestrzak G; Barron J; Rosenberg A; White J; Whitney J; Redberg R; Malenka D
    Curr Med Res Opin; 2014 Sep; 30(9):1707-13. PubMed ID: 24809834
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Current Evidence-Based Understanding of the Epidemiology, Prevention, and Treatment of Atrial Fibrillation.
    Rogers PA; Bernard ML; Madias C; Thihalolipavan S; Mark Estes NA; Morin DP
    Curr Probl Cardiol; 2018 Jun; 43(6):241-283. PubMed ID: 29759117
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The Increasing Role of Rhythm Control in Patients With Atrial Fibrillation: JACC State-of-the-Art Review.
    Camm AJ; Naccarelli GV; Mittal S; Crijns HJGM; Hohnloser SH; Ma CS; Natale A; Turakhia MP; Kirchhof P
    J Am Coll Cardiol; 2022 May; 79(19):1932-1948. PubMed ID: 35550691
    [TBL] [Abstract][Full Text] [Related]  

  • 9. "As Needed" nonvitamin K antagonist oral anticoagulants for infrequent atrial fibrillation episodes following atrial fibrillation ablation guided by diligent pulse monitoring: A feasibility study.
    Zado ES; Pammer M; Parham T; Lin D; Frankel DS; Dixit S; Marchlinski FE
    J Cardiovasc Electrophysiol; 2019 May; 30(5):631-638. PubMed ID: 30706975
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Ablation of Atrial Fibrillation: Patient Selection, Periprocedural Anticoagulation, Techniques, and Preventive Measures After Ablation.
    Link MS; Haïssaguerre M; Natale A
    Circulation; 2016 Jul; 134(4):339-52. PubMed ID: 27462054
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Stroke and Cardiovascular Events After Ablation or Antiarrhythmic Drugs for Treatment of Patients With Atrial Fibrillation.
    Mansour M; Heist EK; Agarwal R; Bunch TJ; Karst E; Ruskin JN; Mahapatra S
    Am J Cardiol; 2018 May; 121(10):1192-1199. PubMed ID: 29571722
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Catheter ablation of atrial fibrillation in patients with hypertrophic cardiomyopathy: atrial fibrillation type determines the success rate.
    Derejko P; Polańska M; Chojnowska L; Michałowska I; Wójcik A; Piotrowicz E; Lech A; Kłopotowski M; Baranowski R; Przybylski A; Bilińska M; Sierpiński R; Walczak F; Szumowski L
    Kardiol Pol; 2013; 71(1):17-24. PubMed ID: 23348529
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Atrial Fibrillation: How Important is Rhythm Control Therapy?].
    Meyer C; Metzner A; Kirchhof P
    Dtsch Med Wochenschr; 2020 Apr; 145(8):543-549. PubMed ID: 32294780
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Catheter ablation of atrial fibrillation: state-of-the-art techniques and future perspectives.
    Santangeli P; Di Biase L; Burkhardt DJ; Horton R; Sanchez J; Bai R; Pump A; Perez M; Wang PJ; Natale A; Al-Ahmad A
    J Cardiovasc Med (Hagerstown); 2012 Feb; 13(2):108-24. PubMed ID: 22193837
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Rate or Rhythm Control of Atrial Fibrillation - Pearls for the Internist.
    Huang W; Keng FY; Ching CK
    Ann Acad Med Singap; 2017 Nov; 46(11):433-438. PubMed ID: 29288262
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Five-year impact of catheter ablation for atrial fibrillation in patients with a prior history of stroke.
    Bunch TJ; May HT; Bair TL; Crandall BG; Cutler MJ; Day JD; Jacobs V; Mallender C; Osborn JS; Weiss JP
    J Cardiovasc Electrophysiol; 2018 Feb; 29(2):221-226. PubMed ID: 29131434
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Anti-arrhythmic strategies for atrial fibrillation: The role of computational modeling in discovery, development, and optimization.
    Grandi E; Maleckar MM
    Pharmacol Ther; 2016 Dec; 168():126-142. PubMed ID: 27612549
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Safety and Efficacy of Uninterrupted Apixaban Therapy Versus Warfarin During Atrial Fibrillation Ablation.
    Shah RR; Pillai A; Schafer P; Meggo D; McElderry T; Plumb V; Yamada T; Kumar V; Doppalapudi H; Gunter A; Pentecost E; Maddox WR
    Am J Cardiol; 2017 Aug; 120(3):404-407. PubMed ID: 28595862
    [TBL] [Abstract][Full Text] [Related]  

  • 19. 2016 ESC Guidelines for the management of atrial fibrillation developed in collaboration with EACTS.
    Kirchhof P; Benussi S; Kotecha D; Ahlsson A; Atar D; Casadei B; Castella M; Diener HC; Heidbuchel H; Hendriks J; Hindricks G; Manolis AS; Oldgren J; Popescu BA; Schotten U; Van Putte B; Vardas P; Agewall S; Camm J; Baron Esquivias G; Budts W; Carerj S; Casselman F; Coca A; De Caterina R; Deftereos S; Dobrev D; Ferro JM; Filippatos G; Fitzsimons D; Gorenek B; Guenoun M; Hohnloser SH; Kolh P; Lip GY; Manolis A; McMurray J; Ponikowski P; Rosenhek R; Ruschitzka F; Savelieva I; Sharma S; Suwalski P; Tamargo JL; Taylor CJ; Van Gelder IC; Voors AA; Windecker S; Zamorano JL; Zeppenfeld K
    Eur J Cardiothorac Surg; 2016 Nov; 50(5):e1-e88. PubMed ID: 27663299
    [No Abstract]   [Full Text] [Related]  

  • 20. The pathology and treatment of cardiac arrhythmias: focus on atrial fibrillation.
    Schmidt C; Kisselbach J; Schweizer PA; Katus HA; Thomas D
    Vasc Health Risk Manag; 2011; 7():193-202. PubMed ID: 21490945
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.